Brief: Allarity Therapeutics Reports Second Quarter 2022 Financial Results
11/10/2022 21:22
Oct 11 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS, PROVIDES RECENT OPERATIONAL HIGHLIGHTS, AND REGAINS
COMPLIANCE WITH NASDAQ LISTING REQUIREMENTS
* ALLARITY THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.72
Source text for Eikon: ID:nGNX722JWq
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic